Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|August 10, 2000
Use of PET in neuroendocrine tumors. In vivo applications and in vitro studiesB Eriksson, M Bergström, H Orlefors, et al.Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2005
Developments in PET for the detection of endocrine tumoursB Eriksson, H Orlefors, K Oberg, et al.Italian Journal of Gastroenterology and Hepatology|December 22, 1999
Positron emission tomography in neuroendocrine tumoursB Eriksson, H Orlefors, A Sundin, et al.Nuclear Medicine and Biology|August 6, 2003
Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmineH Orlefors, A Sundin, K J Fasth, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2005
Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomographyH Orlefors, A Sundin, L Lu, et al.Nordisk Medicin|December 4, 1998
[PET in neuroendocrine tumors]B Eriksson, H Orlefors, A Sundin, et al.Anticancer Research|April 19, 2000
Uptake of 14C- and 11C-labeled glutamate, glutamine and aspartate in vitro and in vivoF Wu, H Orlefors, M Bergström, et al.Anticancer Research|July 1, 1997
Effect of 6-diazo-5-oxo-L-norleucine (DON) on human carcinoid tumor cell aggregatesF Wu, M Bergström, M Stridsberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumorsH Orlefors, A Sundin, H Ahlström, et al.The Journal of Clinical Endocrinology and Metabolism|March 10, 2005
Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomographyH Orlefors, A Sundin, U Garske, et al.Pageof 1